Threonyl-tRNA Synthetase Promotes T Helper Type 1 Cell Responses by Inducing Dendritic Cell Maturation and IL-12 Production via an NF-κB Pathway

被引:16
|
作者
Jung, Hak-Jun [1 ]
Park, Su-Ho [1 ]
Cho, Kyung-Min [1 ]
Jung, Kwang Il [1 ]
Cho, Daeho [2 ]
Kim, Tae Sung [1 ]
机构
[1] Korea Univ, Dept Life Sci, Coll Life Sci & Biotechnol, Seoul, South Korea
[2] Korea Univ, Inst Convergence Sci, Seoul, South Korea
来源
FRONTIERS IN IMMUNOLOGY | 2020年 / 11卷
基金
新加坡国家研究基金会;
关键词
aminoacyl-tRNA synthetase; threonyl-tRNA synthetase; dendritic cell; interleukin-12; type 1 helper T cells; interferon-γ influenza A virus; IFN-GAMMA; CYTOKINES; KINASES;
D O I
10.3389/fimmu.2020.571959
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Threonyl-tRNA synthetase (TRS) is an aminoacyl-tRNA synthetase that catalyzes the aminoacylation of tRNA by transferring threonine. In addition to an essential role in translation, TRS was extracellularly detected in autoimmune diseases and also exhibited pro-angiogenetic activity. TRS is reported to be secreted into the extracellular space when vascular endothelial cells encounter tumor necrosis factor-alpha. As T helper (Th) type 1 response and IFN-gamma levels are associated with autoimmunity and angiogenesis, in this study, we investigated the effects of TRS on dendritic cell (DC) activation and CD4 T cell polarization. TRS-treated DCs exhibited up-regulated expression of activation-related cell-surface molecules, including CD40, CD80, CD86, and MHC class II. Treatment of DCs with TRS resulted in a significant increase of IL-12 production. TRS triggered nuclear translocation of the NF-kappa B p65 subunit along with the degradation of I kappa B proteins and the phosphorylation of MAPKs in DCs. Additionally, MAPK inhibitors markedly recovered the degradation of I kappa B proteins and the increased IL-12 production in TRS-treated DCs, suggesting the involvement of MAPKs as the upstream regulators of NF-kappa B in TRS-induced DC maturation and activation. Importantly, TRS-stimulated DCs significantly increased the populations of IFN-gamma(+)CD4 T cells, and the levels of IFN-gamma when co-cultured with CD4(+) T cells. The addition of a neutralizing anti-IL-12 mAb to the cell cultures of TRS-treated DCs and CD4(+) T cells resulted in decreased IFN-gamma production, indicating that TRS-stimulated DCs may enhance the Th1 response through DC-derived IL-12. Injection of OT-II mice with OVA-pulsed, TRS-treated DCs also enhanced Ag-specific Th1 responses in vivo. Importantly, injection with TRS-treated DC exhibited increased populations of IFN-gamma(+)-CD4(+) and -CD8(+) T cells as well as secretion level of IFN-gamma, resulting in viral clearance and increased survival periods in mice infected with influenza A virus (IAV), as the Th1 response is associated with the enhanced cellular immunity, including anti-viral activity. Taken together, these results indicate that TRS promotes the maturation and activation of DCs, DC-mediated Th1 responses, and anti-viral effect on IAV infection.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis B
    Barth, H
    Klein, R
    Berg, PA
    Wiedenmann, B
    Hopf, U
    Berg, T
    HEPATO-GASTROENTEROLOGY, 2001, 48 (38) : 553 - 555
  • [32] Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: A feedback regulation of Th1 development
    Skok, J
    Poudrier, J
    Gray, D
    JOURNAL OF IMMUNOLOGY, 1999, 163 (08): : 4284 - 4291
  • [33] A synergistic effect of triptolide and curcumin on rheumatoid arthritis by improving cell proliferation and inducing cell apoptosis via inhibition of the IL-17/NF-κB signaling pathway
    Zhang, Chaofeng
    Weng, Yiyang
    Wang, Haibin
    Zhan, Siting
    Li, Chaoqi
    Zheng, Donghui
    Lin, Qi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 142
  • [34] The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
    Kitamura, H
    Iwakabe, K
    Yahata, T
    Nishimura, S
    Ohta, A
    Ohmi, Y
    Sato, M
    Takeda, K
    Okumura, K
    van Kaer, L
    Kawano, T
    Taniguchi, M
    Nishimura, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07): : 1121 - 1127
  • [35] B lymphocytes regulate dendritic cell (DC) function in vivo: Increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation
    Moulin, V
    Andris, F
    Thielemans, K
    Maliszewski, C
    Urbain, J
    Moser, M
    JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (04): : 475 - 482
  • [36] Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses
    Ausiello, CM
    Fedele, G
    Urbani, F
    Lande, R
    Di Carlo, B
    Cassone, A
    JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (03): : 351 - 360
  • [37] An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production
    Kim, TS
    DeKruyff, RH
    Rupper, R
    Maecker, HT
    Levy, S
    Umetsu, DT
    JOURNAL OF IMMUNOLOGY, 1997, 158 (09): : 4137 - 4144
  • [38] Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-κB pathway
    Lodewick, Julie
    Lamsoul, Isabelle
    Polania, Angela
    Lebrun, Sylvie
    Burny, Arsene
    Ratner, Lee
    Bex, Francoise
    VIROLOGY, 2009, 386 (01) : 68 - 78
  • [39] Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T cell responses toward a type 1 pattern
    Li, Q
    Carr, A
    Chang, AE
    FASEB JOURNAL, 2003, 17 (07): : C123 - C123
  • [40] PRDX-1 promotes cell proliferation and inhibits apoptosis of human gliomas via TNF-α/NF-κB pathway
    Liu, Jin-Ge
    Zhang, Ke-Bin
    Tang, Jin-Liang
    Wang, Ya-Li
    Lv, Sheng-Qing
    Xu, Jian-Ping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (03): : 3152 - 3160